Can Blood Thinners After A Heart Stent Really Continue For A Full Year?
After a coronary stent procedure, most patients are prescribed dual antiplatelet therapy, commonly called DAPT.
This involves taking two blood thinning medications together to reduce the risk of dangerous blood clots forming inside the new stent.
The length of treatment depends on why the stent was required and the patient’s individual bleeding risk.
How Long Is DAPT Usually Required?
For planned stent procedures treating stable angina, dual therapy is commonly prescribed for around 6 months.
Patients treated after a heart attack usually require 12 months of therapy because the risk of further clotting remains higher during recovery.
Treatment length may sometimes be shortened or extended depending on individual circumstances.
Why The Timeline Matters
The duration of DAPT is carefully balanced.
Stopping treatment too early can increase the risk of stent thrombosis, where a clot forms suddenly inside the stent.
Remaining on dual therapy too long may increase the risk of bleeding complications.
Cardiologists use clinical scoring systems and patient history to determine the safest treatment duration.
What Can Change The Treatment Length?
Several factors may influence whether therapy is shortened or extended:
Previous bleeding problems
Multiple stents
Diabetes
Complex coronary artery disease
Tolerance of medication
High future heart attack risk
Modern treatment plans are increasingly personalised.
What Happens After Dual Therapy Ends?
Most patients do not stop blood thinning treatment completely after DAPT finishes.
Instead, they usually continue lifelong single antiplatelet therapy, often low dose aspirin, to provide ongoing cardiovascular protection.
%20Cover%20(9).png)
Comments
Post a Comment